Valuation (43%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 42.93 | N/A |
| PEG Ratio (TTM) | -6.11 | N/A |
| P/S Ratio (TTM) | 8.33 | N/A |
| P/B Ratio (TTM) | 3.26 | N/A |
| P/FCF Ratio (TTM) | 33.32 | N/A |
| Price to 5YR AVG Earnings Ratio | 33.22 | N/A |
| Price to 5YR AVG FCF Ratio | 28.83 | N/A |
Profitability (40%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 4.83% | N/A |
| ROE (TTM) | 7.48% | N/A |
| Net Profit Margin (TTM) | 19.43% | N/A |
| ROIC 5YR AVG | 10.21% | N/A |
Growth (72%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -7.09% | 37.11% | 17.76% |
| Revenue | 13.61% | 15.54% | 5.88% |
| Net Income | -7.51% | 37.04% | 17.85% |
| Cash Flow | -1.88% | 29.99% | 15.20% |
Health (49%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.37 | N/A |
| Quick Ratio (TTM) | 1.01 | N/A |
| D/E Ratio (TTM) | 0.34 | N/A |
| Interest Coverage (TTM) | 13.49 | N/A |
| Piotroski F-Score | 5 | N/A |
| Altman Z-Score | 4.65 | N/A |
| LTL to 5YR AVG FCF | 3.05 | N/A |
| Shares Outstanding Growth 5YR AVG | 1.01% | N/A |